Novo begins R&D tie-up with AI biotech e-TherapeuticsNovo Nordisk has signed a deal with UK biotech e-Therapeutics to use its AI-based drug discovery technology to Share XNovo begins R&D tie-up with AI biotech e-Therapeuticshttps://pharmaphorum.com/news/novo-begins-rd-tie-up-with-ai-biotech-e-therapeutics/
Axovant axes neuroscience drug, focuses on gene therapiesSwiss biotech Axovant started the year badly, dropping its Alzheimer’s drug intepirdine after it failed in a trial, Share XAxovant axes neuroscience drug, focuses on gene therapieshttps://pharmaphorum.com/news/axovant-axes-neuroscience-drug-focuses-on-gene-therapies/
Shinichi Tamura re-takes CEO role at SoseiSosei has announced that its founder and former CEO Shinichi Tamura will be re-taking the position of CEO Share XShinichi Tamura re-takes CEO role at Soseihttps://pharmaphorum.com/news/shinichi-tamura-re-takes-ceo-role-sosei/
Eisai, Takeda and GARDP hunt for new antibioticsThe not-for-profit Global Antibiotic Research and Development Partnership has joined forces with Eisai and Takeda to search for Share XEisai, Takeda and GARDP hunt for new antibioticshttps://pharmaphorum.com/news/eisai-takeda-and-gardp-hunt-for-new-antibiotics/
FDA clears Pear/Sandoz app for opioid use disorderA second mobile app developed by Pear Therapeutics to help opioid use disorder patients who have a more Share XFDA clears Pear/Sandoz app for opioid use disorderhttps://pharmaphorum.com/news/fda-clears-pear-sandoz-app-for-opioid-use-disorder/
Clark Health Communications forms alliance with EggLondon-based consultancy Clark Health Communications is partnering with digital solutions agency Egg in a collaboration that will see Share XClark Health Communications forms alliance with Egghttps://pharmaphorum.com/news/clark-health-communications-egg-digital/
NICE reveals new standards for digital techNICE has published new standards setting out the requirements needed to develop digital health technologies for the NHS Share XNICE reveals new standards for digital techhttps://pharmaphorum.com/news/nice-reveals-new-standards-for-digital-tech/
Generics firms the ‘biggest cartel in US history’ – reportUS authorities looking into price fixing in the generics industry are now investigating 16 companies and the price Share XGenerics firms the ‘biggest cartel in US history’ – reporthttps://pharmaphorum.com/news/generics-firms-the-biggest-cartel-in-us-history-report/
Akorn searches for new CEO after failed Fresenius mergerUS generics firm Akorn is searching for a new CEO in the wake of a failed merger with Share XAkorn searches for new CEO after failed Fresenius mergerhttps://pharmaphorum.com/news/akorn-searches-for-new-ceo-after-failed-fresenius-merger/
Certain brain tumours could respond to immunotherapySome brain tumours may respond to immunotherapy after all, according to a new study. So far, brain tumours Share XCertain brain tumours could respond to immunotherapyhttps://pharmaphorum.com/news/certain-brain-tumours-could-respond-to-immunotherapy/
Boehringer follows Sanofi with job cuts in FranceBoehringer Ingelheim has confirmed it plans to axe more than 10% of its workforce in France, or more Share XBoehringer follows Sanofi with job cuts in Francehttps://pharmaphorum.com/news/boehringer-follows-sanofi-with-job-cuts-in-france/
Fishawack acquires marketing consultancy Blue Latitude HealthPictured: Dominic Miller, Fred Bassett, Oliver Dennis (back row from left to right), Martin Brass, Gail Flockhart (front row Share XFishawack acquires marketing consultancy Blue Latitude Healthhttps://pharmaphorum.com/news/fishawack-acquires-marketing-consultancy-blue-latitude-health/
Merck KGaA links with AI firm to iron out side-effects during R&DGermany’s Merck KGaA has begun a licensing agreement with Canadian pharma R&D company Cyclica using artificial intelligence (AI) Share XMerck KGaA links with AI firm to iron out side-effects during R&Dhttps://pharmaphorum.com/news/merck-kgaa-links-with-ai-firm-to-iron-out-side-effects-during-rd/
AZ and CRUK team up to go all-in on CRISPRAstraZeneca and Cancer Research UK are collaborating to launch a centre of excellence in genetic screening, cancer modelling Share XAZ and CRUK team up to go all-in on CRISPRhttps://pharmaphorum.com/news/az-cruk-crispr/
Gilead hires Roche’s pharma chief Daniel O’Day as CEORoche executive Daniel O’Day is to take the helm at Gilead after John Milligan steps down as CEO Share XGilead hires Roche’s pharma chief Daniel O’Day as CEOhttps://pharmaphorum.com/news/gilead-hires-roches-pharma-chief-daniel-oday-as-ceo/
Pharma companies warned over ‘no deal’ Brexit disruptionThe government is asking pharma companies to introduce additional measures, over and above the stockpiles already in place, Share XPharma companies warned over ‘no deal’ Brexit disruptionhttps://pharmaphorum.com/news/pharma-companies-warned-over-no-deal-brexit-disruption/
Moderna shares slide after record $604m US listingRNA drug specialist Moderna smashed the record for an initial public offering (IPO) in the US on Friday, Share XModerna shares slide after record $604m US listinghttps://pharmaphorum.com/news/moderna-shares-slide-after-record-604m-us-listing/
Awards for AI-based drug R&D continue for second yearUK health technology firm BenevolentAI and the Association of Medical Research Charities are continuing an award encouraging use Share XAwards for AI-based drug R&D continue for second yearhttps://pharmaphorum.com/news/awards-for-ai-based-drug-rd-continue-for-second-year/
Hear from PFS industry leaders from big pharma & government bodies Share XHear from PFS industry leaders from big pharma & government bodieshttps://pharmaphorum.com/partner-content/hear-from-pfs-industry-leaders-from-big-pharma-government-bodies/
Invite from James Drinkwater Chairing 2nd Annual Pharmaceutical Microbiology East Coast Share XInvite from James Drinkwater Chairing 2nd Annual Pharmaceutical Microbiology East Coasthttps://pharmaphorum.com/partner-content/invite-from-james-drinkwater-chairing-2nd-annual-pharmaceutical-microbiology-east-coast/
The Strategies to Reach Out and Engage with Your Customers Share XThe Strategies to Reach Out and Engage with Your Customershttps://pharmaphorum.com/partner-content/the-strategies-to-reach-out-and-engage-with-your-customers/
Registration opens for the 11th Adaptive Designs in Clinical Trials Share XRegistration opens for the 11th Adaptive Designs in Clinical Trialshttps://pharmaphorum.com/partner-content/registration-opens-for-the-11th-adaptive-designs-in-clinical-trials/
pharmaphorum welcomes George Underwood to its editorial helm Share Xpharmaphorum welcomes George Underwood to its editorial helmhttps://pharmaphorum.com/news/pharmaphorum-welcomes-george-underwood-to-its-editorial-helm/
STEM Healthcare appoints Jason McKenna as CEO Share XSTEM Healthcare appoints Jason McKenna as CEOhttps://pharmaphorum.com/partner-content/stem-healthcare-appoints-jason-mckenna-as-ceo/
